<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hou SM</submitter><funding>National Science and Technology Council, Taiwan</funding><funding>Shin Kong Wu Ho-Su Memorial Hospital</funding><funding>Chi Mei Medical Center-Taipei Medical University</funding><funding>Cathay General Hospital</funding><pagination>174</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11853366</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>Inflammation, a fundamental response to infection and injury, involves interactions among immune cells and signaling molecules. Dysregulated inflammation contributes to diseases such as autoimmune disorders and cancer. Interleukin-1 beta (IL-1β), produced by macrophages in response to lipoteichoic acid (LTA) from Gram-positive bacteria, is a key inflammatory mediator. Glabridin (GBD), a bioactive compound from licorice root, exhibits anti-inflammatory properties. This study investigates GBD's effects on LTA-induced proinflammatory signaling in RAW 264.7 murine macrophages and alveolar macrophages, MH-S, focusing on &lt;i>IL-1β&lt;/i> expression and signaling pathways. Cell viability assays confirmed that 20 μM GBD was non-cytotoxic. Confocal microscopy and quantitative PCR showed that GBD signif</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Glabridin Suppresses Macrophage Activation by Lipoteichoic Acid In Vitro: The Crucial Role of MAPKs-IL-1β-iNOS Axis Signals in Peritoneal and Alveolar Macrophages.</pubmed_title><pmcid>PMC11853366</pmcid><funding_grant_id>2023SKHAND006</funding_grant_id><funding_grant_id>MOST 110-2320-B341-001-MY3</funding_grant_id><funding_grant_id>NSTC 113-2320-B341-002-MY3</funding_grant_id><funding_grant_id>110CM-TMU-18</funding_grant_id><funding_grant_id>CGH-MR-A11226</funding_grant_id><funding_grant_id>2024SKHAND008</funding_grant_id><pubmed_authors>Hsia CH</pubmed_authors><pubmed_authors>Hou SM</pubmed_authors><pubmed_authors>Hsia CW</pubmed_authors><pubmed_authors>Cheng SW</pubmed_authors><pubmed_authors>Yang CM</pubmed_authors><pubmed_authors>Yen TL</pubmed_authors><pubmed_authors>Hsieh CY</pubmed_authors><pubmed_authors>Huang WC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glabridin Suppresses Macrophage Activation by Lipoteichoic Acid In Vitro: The Crucial Role of MAPKs-IL-1β-iNOS Axis Signals in Peritoneal and Alveolar Macrophages.</name><description>Inflammation, a fundamental response to infection and injury, involves interactions among immune cells and signaling molecules. Dysregulated inflammation contributes to diseases such as autoimmune disorders and cancer. Interleukin-1 beta (IL-1β), produced by macrophages in response to lipoteichoic acid (LTA) from Gram-positive bacteria, is a key inflammatory mediator. Glabridin (GBD), a bioactive compound from licorice root, exhibits anti-inflammatory properties. This study investigates GBD's effects on LTA-induced proinflammatory signaling in RAW 264.7 murine macrophages and alveolar macrophages, MH-S, focusing on &lt;i>IL-1β&lt;/i> expression and signaling pathways. Cell viability assays confirmed that 20 μM GBD was non-cytotoxic. Confocal microscopy and quantitative PCR showed that GBD signif</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-22T20:07:18.333Z</modification><creation>2025-04-06T03:01:47.528Z</creation></dates><accession>S-EPMC11853366</accession><cross_references><pubmed>40001477</pubmed><doi>10.3390/biom15020174</doi></cross_references></HashMap>